Factors associated with selection of targeted therapy in patients with rheumatoid arthritis.

Yeo-Jin SongSoo-Kyung ChoHyoungyoung KimHye Won KimEunwoo NamChan-Bum ChoiTae-Hwan KimJae-Bum JunSang-Cheol BaeDae Hyun YooYoon-Kyoung Sung

Published in: PloS one (2023)

Age, pulmonary comorbidities, previous tacrolimus use, and high disease activity assessed by physician were factors influencing the selection of JAKis for RA patients in Korea.

Keyphrases

disease activity
rheumatoid arthritis
systemic lupus erythematosus
ankylosing spondylitis
rheumatoid arthritis patients
end stage renal disease
ejection fraction
primary care
newly diagnosed
emergency department
juvenile idiopathic arthritis
pulmonary hypertension
interstitial lung disease